Twist Bioscience CorporationTWSTNASDAQ
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank11
Studio
Year-over-Year Change

Year-over-year research & development expense growth

Percentile
P11
Within normal range
vs 5Y Ago
-0.6x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
2025-11.63%
2024-15.01%
2023-11.15%
202274.18%
202160.61%
202020.52%
201975.37%
20186.15%
20175.15%
20160.00%